Endoscopy 2021; 53(03): 337-338
DOI: 10.1055/a-1319-1496
COVID-19 communication

Potential use of a novel telemetric sensor capsule in patients with suspected gastrointestinal bleeding during the COVID-19 pandemic

Ismaeil Elsayed
Department of Internal Medicine I, Hospital Ludwigsburg, Ludwigsburg, Germany
,
Benjamin Meier
Department of Internal Medicine I, Hospital Ludwigsburg, Ludwigsburg, Germany
,
Karel Caca
Department of Internal Medicine I, Hospital Ludwigsburg, Ludwigsburg, Germany
,
Andreas Wannhoff
Department of Internal Medicine I, Hospital Ludwigsburg, Ludwigsburg, Germany
› Author Affiliations

Upper gastrointestinal endoscopy during the COVID-19 pandemic carries a risk of disease transmission [1] [2]. The HemoPill (Ovesco Endoscopy, Tübingen, Germany) is composed of an orally administered telemetric sensor capsule that is capable of detecting blood and hematin, and a wireless receiver for data display [3] [4] [5]. Results are expressed as the HemoPill indicator (HI). A HI value ≥ 0.8 during the first 10 minutes of the examination or ≥ 1.0 thereafter denotes a positive test result. We evaluated this sensor capsule in patients with confirmed or suspected COVID-19.

Case #1 was a patient with COVID-19, congestive heart failure, and severe obesity who reported melena and had a drop of hemoglobin from 14.6 g/dL to 11.3 g/dL. She required low-flow oxygen but was otherwise clinically stable. The maximum HI value was 1.0 after 89 minutes ([Fig. 1a]). Endoscopy subsequently showed a gastric ulcer with a non-bleeding visible vessel ([Fig. 1b]).

Zoom Image
Fig. 1 Images of HemoPill examination in two patients showing: a a screenshot of the HemoPill Receiver in patient #1, which revealed a maximum HI of 1.0 after 89 minutes of examination, therefore denoting a positive test result; b endoscopic image in patient #1, with a non-spurting visible vessel identified in the stomach that was treated with through-the-scope clips; c a screenshot of the HemoPill Receiver in patient #2, which revealed a negative test result; d a photograph of the HemoPill capsule, an orally administered telemetric sensor capsule capable of detecting liquid blood or hematin.

Patient #2 suffered from dyspnea and anemia (hemoglobin 4.3 g/dL) with possible gastrointestinal bleeding. She was routinely tested for SARS-CoV-2 and isolated until receipt of her result. The maximum HI value was 0.2 ([Fig. 1c]). Her endoscopy, which showed no evidence of gastrointestinal bleeding, was postponed for 48 hours until receipt of negative test result.

Patient #3 suffered from COVID-19 and was therefore receiving anticoagulant therapy. He underwent endoscopic retrograde cholangioscopy with papillotomy because of biliary pancreatitis; he reported a single episode of hematochezia 1 week after the endoscopy and his hemoglobin had dropped by 4.5 g/dL to 7.9 g/dL. His maximum HI value was 0.8 and no endoscopy was performed. No further episodes of bleeding were reported and the patient’s hemoglobin remained stable.

This sensor capsule ([Fig. 1 d]) might aid in decision-making during the COVID-19 pandemic. In patients with as yet unavailable COVID-19 test results, it might aid in determining the appropriate timepoint for endoscopy. In patients who are positive for COVID-19 with suspected gastrointestinal bleeding, it could help in deciding whether to perform an endoscopy or not and thereby potentially help minimizing risk of disease transmission.



Publication History

Article published online:
13 January 2021

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Wölfel R, Corman VM, Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465-469
  • 2 Gralnek IM, Hassan C, Beilenhoff U. et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic. Endoscopy 2020; 52: 483-490
  • 3 Schmidt A, Zimmermann M, Bauder M. et al. Novel telemetric sensor capsule for EGD urgency triage: a feasibility study. Endosc Int Open 2019; 7: E774-E781
  • 4 Schostek S, Zimmermann M, Keller J. et al. Pre-clinical study on a telemetric gastric sensor for recognition of acute upper gastrointestinal bleeding: the "HemoPill monitor". Surg Endosc 2020; 34: 888-898
  • 5 Schostek S, Zimmermann M, Keller J. et al. Volunteer case series of a new telemetric sensor for blood detection in the upper gastrointestinal tract: The HemoPill. Dig Dis Sci 2016; 61: 2956-2962